 8. Patients who have received chemotherapy, any investigational drug or undergone major surgery within 3 weeks prior to starting study drug or who have not recovered from side effects of such therapy CTCAE Grade 1, with the exception of nitrosoureas, which should be discontinued at least six weeks before enrollment. 